Quantitative determination of sirolimus in dog blood using liquid chromatography-tandem mass spectrometry, and its applications to pharmacokinetic studies

J Pharm Biomed Anal. 2010 Dec 1;53(4):1042-7. doi: 10.1016/j.jpba.2010.06.030. Epub 2010 Jul 7.

Abstract

A rapid, sensitive method of detecting sirolimus in blood was developed and applied in pharmacokinetic studies employing deionized water for hemolysis and a weakly basic mobile phase to enhance chromatographic peak intensity. Dog blood samples were processed via liquid-liquid extraction and the amounts of sirolimus and tacrolimus, an internal standard, were quantified by LC-MS/MS. Specificity, the lower limit of quantification, linearity, accuracy, precision, dilution, recovery, matrix effects, robustness and stability were within the acceptable range for assay validation. The concentration of sirolimus was quantifiable in blood samples for up to 36 h after the dog had received a 3 mg/kg dose of sirolimus. These observations suggest that sirolimus can be detected at low levels in dog blood using a basic mobile phase and metal-free hemolysis. This method is therefore applicable to pharmacokinetic studies in dogs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calibration
  • Chromatography, Liquid / methods*
  • Dogs
  • Drug Stability
  • Immunosuppressive Agents / blood*
  • Limit of Detection
  • Sirolimus / blood*
  • Sirolimus / chemistry
  • Sirolimus / pharmacokinetics
  • Tandem Mass Spectrometry / methods*

Substances

  • Immunosuppressive Agents
  • Sirolimus